• Expanded List of Products Subject to Large Trader Reporting of Physical Commodity Swaps under CFTC Part 20 Regulations

      • To
      • Members, Member Firms and Market Users
      • From
      • Market Regulation Department
      • #
      • CME Group RA1202-5
      • Notice Date
      • 18 January 2012
      • Effective Date
      • 18 January 2012
    • This Market Regulation Advisory Notice supplements Market Regulation Advisory Notice RA1104-5 from October 19, 2011, and contains an expanded list of products subject to large trader reporting requirements under the CFTC’s Part 20 Regulations (Large Trader Reporting for Physical Commodity Swaps).  

       

      Recently, after discussions with the CFTC, CME Group believes that the following CME and CBOT swap products are also subject to the reporting requirements set forth in the Part 20 Regulations: 

                                                                                                                             

      Clearing                Product                                                                                                                 Designated Clearing

      Code                      Name                                                                                                                     Organization (DCO)

       

      ERF                         S&P GSCI Excess Return Forward Swap                                                                            CME

      SE3                         S&P GSCI ER Index 3 Month Forward Swaps                                                                    CME

      SE2                         S&P GSCI ER Index 2 Month Forward Swaps                                                                    CME
      SES                         S&P GSCI Excess Return Index Swap                                                                                CME

      GD1                        S&P GSCI ER Gold Swap                                                                                                     CME

      GCO                       S&P GSCI Crude Oil ER Swap                                                                                             CME

      DGS                        Dow Jones-UBS Commodity Index Swap                                                                         CBOT

      DG2                        DJ-UBS CI ER Index 2 Month Forward Swap                                                                    CBOT

      DG3                        DJ-UBS CI ER Index 3 Month Forward Swap                                                                     CBOT

       

      These nine products, in addition to the five products set forth in RA1104-5 (reproduced below), must be reported pursuant to the Part 20 Regulations.

       

      Clearing                Product                                                                                                                 Designated Clearing

      Code                      Name                                                                                                                     Organization (DCO)

       

      71                            Denatured Fuel Ethanol Forward Month Swaps                                                                 CBOT

      71                            Cash-Settled Options on Denatured Fuel Ethanol Forward-Month Calendar Swaps         CBOT

      CCS                        Corn Calendar Swap                                                                                                           CBOT

      SNS                         Soybean Calendar Swap                                                                                                   CBOT

      WCS                       Wheat Calendar Swap                                                                                                        CBOT

       

      To view the complete text of RA1104-5, please click here or visit the Market Regulation section of the CME Group website at www.cmegroup.com/rulebook/rulebook-harmonization.html.

       

      Questions regarding this Advisory Notice may be directed to the following individuals in Market Regulation:

       

      Joe Hawrysz, Director, 312.341.7750

      James Moran, Director, 312.435.3671

       

      For media inquiries concerning this Advisory Notice, please contact CME Group Corporate Communications at 312.930.3434 or news@cmegroup.com.